These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 32931540)
1. Facile one-pot synthesis of cyclic peptide-conjugated photosensitisers for targeted photodynamic therapy. Chu JCH; Yang C; Fong WP; Wong CTT; Ng DKP Chem Commun (Camb); 2020 Oct; 56(80):11941-11944. PubMed ID: 32931540 [TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy. Conway CL; Walker I; Bell A; Roberts DJ; Brown SB; Vernon DI Photochem Photobiol Sci; 2008 Mar; 7(3):290-8. PubMed ID: 18389145 [TBL] [Abstract][Full Text] [Related]
3. One-pot peptide cyclisation and surface modification of photosensitiser-loaded red blood cells for targeted photodynamic therapy. Chu JCH; Shao C; Ha SYY; Fong WP; Wong CTT; Ng DKP Biomater Sci; 2021 Nov; 9(23):7832-7837. PubMed ID: 34726672 [TBL] [Abstract][Full Text] [Related]
4. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity. Frochot C; Di Stasio B; Vanderesse R; Belgy MJ; Dodeller M; Guillemin F; Viriot ML; Barberi-Heyob M Bioorg Chem; 2007 Jun; 35(3):205-20. PubMed ID: 17223161 [TBL] [Abstract][Full Text] [Related]
5. Facile Synthesis of Cyclic Peptide-Phthalocyanine Conjugates for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy. Chu JCH; Fong WP; Wong CTT; Ng DKP J Med Chem; 2021 Feb; 64(4):2064-2076. PubMed ID: 33577327 [TBL] [Abstract][Full Text] [Related]
6. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma. Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers. Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel dimeric and tetrameric cRGD-paclitaxel conjugates for integrin-assisted drug delivery. Bianchi A; Arosio D; Perego P; De Cesare M; Carenini N; Zaffaroni N; De Matteo M; Manzoni L Org Biomol Chem; 2015 Jul; 13(27):7530-41. PubMed ID: 26074454 [TBL] [Abstract][Full Text] [Related]
9. Multimerization Increases Tumor Enrichment of Peptide⁻Photosensitizer Conjugates. Zhao J; Li S; Jin Y; Wang JY; Li W; Wu W; Hong Z Molecules; 2019 Feb; 24(4):. PubMed ID: 30823562 [TBL] [Abstract][Full Text] [Related]
10. Thienopyrrole-expanded BODIPY as a potential NIR photosensitizer for photodynamic therapy. Yang Y; Guo Q; Chen H; Zhou Z; Guo Z; Shen Z Chem Commun (Camb); 2013 May; 49(38):3940-2. PubMed ID: 23536148 [TBL] [Abstract][Full Text] [Related]
11. Ligands for mapping alphavbeta3-integrin expression in vivo. Schottelius M; Laufer B; Kessler H; Wester HJ Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and photodynamic activities of integrin-targeting silicon(IV) phthalocyanine-cRGD conjugates. Zheng BY; Yang XQ; Zhao Y; Zheng QF; Ke MR; Lin T; Chen RX; Ho KKK; Kumar N; Huang JD Eur J Med Chem; 2018 Jul; 155():24-33. PubMed ID: 29852329 [TBL] [Abstract][Full Text] [Related]
13. An integrin-targeted photoactivatable Pt(IV) complex as a selective anticancer pro-drug: synthesis and photoactivation studies. Gandioso A; Shaili E; Massaguer A; Artigas G; González-Cantó A; Woods JA; Sadler PJ; Marchán V Chem Commun (Camb); 2015 Jun; 51(44):9169-72. PubMed ID: 25947177 [TBL] [Abstract][Full Text] [Related]
14. Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy. Srivatsan A; Ethirajan M; Pandey SK; Dubey S; Zheng X; Liu TH; Shibata M; Missert J; Morgan J; Pandey RK Mol Pharm; 2011 Aug; 8(4):1186-97. PubMed ID: 21702452 [TBL] [Abstract][Full Text] [Related]
15. A novel distyryl boron dipyrromethene with two functional tags for site-specific bioorthogonal photosensitisation towards targeted photodynamic therapy. Guo X; Wong RCH; Zhou Y; Ng DKP; Lo PC Chem Commun (Camb); 2019 Nov; 55(90):13518-13521. PubMed ID: 31608902 [TBL] [Abstract][Full Text] [Related]
16. cRGD Peptide-Conjugated Pyropheophorbide-a Photosensitizers for Tumor Targeting in Photodynamic Therapy. Li W; Tan S; Xing Y; Liu Q; Li S; Chen Q; Yu M; Wang F; Hong Z Mol Pharm; 2018 Apr; 15(4):1505-1514. PubMed ID: 29502410 [TBL] [Abstract][Full Text] [Related]
17. Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review. Kue CS; Ng SY; Voon SH; Kamkaew A; Chung LY; Kiew LV; Lee HB Photochem Photobiol Sci; 2018 Nov; 17(11):1691-1708. PubMed ID: 29845993 [TBL] [Abstract][Full Text] [Related]